UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

Variable results after rituximab in neuromyelitis optica

Journal of the neurological sciences, 2012-06, Vol.317 (1), p.103-105

2012

Volltextzugriff (PDF)

Sudden unexpected death on fingolimod

Multiple sclerosis, 2012-10, Vol.18 (10), p.1507-1508

2012

Volltextzugriff (PDF)

Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

Multiple sclerosis, 2009-02, Vol.15 (2), p.153-158

2009

Volltextzugriff (PDF)

PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Multiple sclerosis, 2008-03, Vol.14 (2), p.147-152

2008

Volltextzugriff (PDF)

P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD participants with history of immunosuppression treatment prior to N-MOmentum study

Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S17-S17

2024

Volltextzugriff (PDF)

The antibody response to Epstein–Barr virions is altered in multiple sclerosis

Journal of neuroimmunology, 2013-01, Vol.254 (1), p.146-153

2013

Volltextzugriff (PDF)

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

Multiple sclerosis and related disorders, 2012-04, Vol.1 (2), p.81-86

2012

Volltextzugriff (PDF)

Role of monkey midbrain near-response neurons in phoria adaptation

Journal of neurophysiology, 1992-06, Vol.67 (6), p.1475-1492

1992

Volltextzugriff (PDF)

Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis

The Journal of immunology (1950), 1993-05, Vol.150 (9), p.4085-4092

1993

Volltextzugriff (PDF)

ACUTE EFFECTS OF A BICYCLOPHOSPHATE NEUROCONVULSANT ON MONOAMINE NEUROTRANSMITTER AND METABOLITE LEVELS IN THE RAT BRAIN

Journal of Toxicology and Environmental Health, Part A, 1998-07, Vol.54 (5), p.421-429

1998

Volltextzugriff (PDF)

Tissue distribution, metabolism, and clearance of the convulsant trimethylolpropane phosphate in rats

Drug metabolism and disposition, 1998-11, Vol.26 (11), p.1058

1998

Volltextzugriff (PDF)

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Multiple sclerosis, 2015-09, Vol.21 (10), p.1322-1331

2015

Volltextzugriff (PDF)

T cell-T cell activation in multiple sclerosis

Multiple sclerosis, 1997-08, Vol.3 (4), p.238-242

1997

Volltextzugriff (PDF)

An alkali-soluble factor present in normal brain tissue inhibits antigen-specific lymphocyte proliferation

Journal of neuroimmunology, 2000-02, Vol.103 (1), p.76-83

Lindsey, J.William

2000

Volltextzugriff (PDF)

Perspectives on the U.S.-Mexico Soccer Rivalry: Passion and Politics in Red, White, Blue, and Green

1st ed. 2017 edition., 2017

Volltextzugriff (PDF)

Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim

Journal of the neurological sciences, 2012-08, Vol.319 (1), p.172-172

2012

Volltextzugriff (PDF)

Measuring the cellular immune response against Epstein-Barr virus in multiple sclerosis

Multiple sclerosis, 2008-09, Vol.14, p.S230-S230

2008

Volltextzugriff (PDF)

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-04, Vol.6 (4), p.255-266

2000

Volltextzugriff (PDF)

Reinduction of Experimental Autoimmune Encephalomyelitis in Mice

Cellular immunology, 1995-05, Vol.162 (2), p.235-240

1995

Volltextzugriff (PDF)

Multiple sclerosis: clinical presentation, diagnosis and treatment

American family physician, 1996-09, Vol.54 (4), p.1301

1996

Volltextzugriff (PDF)

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the I5-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates

Multiple sclerosis, 2001-02, Vol.7 (1), p.33-41

2001

Volltextzugriff (PDF)

Review: PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Multiple Sclerosis Journal, 2008-03, Vol.14 (2), p.147-152

2008

Volltextzugriff (PDF)

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2008-09, Vol.14, p.S41-S41

2008

Volltextzugriff (PDF)

1 – 25 von 1.415

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.221)
Mit Volltextzugriff
(1.204)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(940)
Life Sciences & Biomedicine
(687)
Humans
(377)
Animals
(203)
Physical Sciences
(199)
Male
(197)
Female
(196)
Biological And Medical Sciences
(123)
Adult
(102)
Middle Aged
(90)
Chemistry
(89)
Technology
(87)
Medical Sciences
(79)
Biochemistry & Molecular Biology
(76)
Social Sciences
(70)
Mice
(66)
Aged
(60)
Fundamental And Applied Biological Sciences. Psychology
(56)
Child
(55)
Exact Sciences And Technology
(54)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Variable results after rituximab in neuromyelitis optica

Sudden unexpected death on fingolimod

Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis

PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD participants with history of immunosuppression treatment prior to N-MOmentum study

The antibody response to Epstein–Barr virions is altered in multiple sclerosis

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

Role of monkey midbrain near-response neurons in phoria adaptation

Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis

ACUTE EFFECTS OF A BICYCLOPHOSPHATE NEUROCONVULSANT ON MONOAMINE NEUROTRANSMITTER AND METABOLITE LEVELS IN THE RAT BRAIN

Tissue distribution, metabolism, and clearance of the convulsant trimethylolpropane phosphate in rats

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

T cell-T cell activation in multiple sclerosis

An alkali-soluble factor present in normal brain tissue inhibits antigen-specific lymphocyte proliferation

Perspectives on the U.S.-Mexico Soccer Rivalry: Passion and Politics in Red, White, Blue, and Green

Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim

Measuring the cellular immune response against Epstein-Barr virus in multiple sclerosis

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Reinduction of Experimental Autoimmune Encephalomyelitis in Mice

Multiple sclerosis: clinical presentation, diagnosis and treatment

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the I5-year analysis of the US prospective open-label study of glatiramer acetate

United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates

Review: PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Aktive Filter

Suchergebnisse filtern